Target intelligence / Profile preview

PLLP pseudogene 1 (PLLPP1)

Target
PLLPP1
Molecular classification
Other (Pseudogene)
01

Overview

**PLLP pseudogene 1 (PLLPP1)** is classified as a pseudogene, meaning it is a segment of DNA that resembles the functional PLLP (Plasmolipin) gene but does not encode a functional protein. Like other pseudogenes, PLLPP1 is considered non-coding and is not involved in coding for any receptor, enzyme, transporter, or protein with a known biological function. There is no evidence that PLLPP1 serves as a therapeutic drug target, nor does it have recognized roles in disease, drug interactions, or serve as a biomarker. Pseudogenes such as PLLPP1 may still participate in gene regulation through RNA-mediated mechanisms, but no functional data specific to PLLPP1 is available[3][4][2].\n\n**Additional context:** \nPLLP (Plasmolipin), not its pseudogene, is involved in myelin formation and nervous system function, but the pseudogene itself—PLLPP1—does not share these biological functions[1][3]. Pseudogenes can sometimes regulate their parental genes as non-coding RNAs, but there is no direct evidence that PLLPP1 has such a role at present[4]. \n\n**Summary of issues:** \nPLLPP1 is not a drug target, not a functional protein, and there is insufficient evidence for any regulatory, biological, or disease involvement. This makes it an incorrect entry if seeking a therapeutic target or actionable biological molecule. \n\n**If you require information on the functional gene (PLLP/Plasmolipin), specify for accurate details on a target protein.**

Other names
PLLP Pseudogene 1
02

Biological functions

Other (No protein-coding function; potential role in gene regulation unclear)

Beyond the preview

Go deeper on PLLP pseudogene 1 (PLLPP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PLLP pseudogene 1 (PLLPP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call